Abstract:To decipher the difference in TME between younger and elder patients with lung cancers. Distinct immune profiles between younger and elderly patients. The immune profiles of elder patients with non-small cell lung cancer (NSCLC) differ significantly from those of younger patients. The tumor microenvironment (TME) is a crucial factor in cancer progression and therapeutic responses. The present study aims to decipher the difference in TME between younger and elderly patients with lung cancers. We downloaded single-cell RNA data from public databases. The algorithm of uniform manifold approximation and projection (UMAP) was applied to cluster and visualize single-cell sequencing data. Gene set variation analysis (GSVA) and gene set enrichment analysis (GSEA) analysis were performed to evaluate the physiological functional characteristics in sub-group cells. CellPhoneDB was used to identify cell–cell interactions between immune cells within TME. We conducted single-cell RNA sequencing on 96,491 cells from elderly patients and 169,207 cells from younger patients, respectively. We observed that epithelial cells were the predominant component of the TME in younger patients, whereas T/NK cells were the predominant cell type in the TME of elderly patients. We also found that there was a higher proportion of Tregs and a lower proportion of NK, effector CD8+T and γδT cells in elder patients compared with younger patients. In addition, a comparative GSEA analysis of NK cells between older and younger patients revealed that the pathways of Parkinson's disease, Alzheimer's disease, mismatch repair, and base excision repair were up-regulated in NK cells from elderly patients, while the pathways related to natural killer cell-mediated cytotoxicity and allograft rejection were downregulated. Furthermore, we identified tumor-associated neutrophils (TANs) in elder patients, and GSVA analysis demonstrated that the pathway of angiogenesis was upregulated, and the pathway of interferon_γ_response, inflammatory_response, TNFα_signaling_via_NFκB pathways were downregulated. Importantly, the pro-inflammatory response scores of complement C1q C chain positive (C1QC+) macrophages, tissue-resident macrophages (TRM), non-classical monocytes (NCM), secreted phosphoprotein 1 positive (SPP1+) macrophages, and classical monocytes (CM) in elder patients were significantly lower compared to those in younger patients. Finally, cell-to-cell communication analyses unveiled the disparities in regulatory patterns between elder and younger patients, namely the pairs of CXCL13-ACKR4 and CSF1-SIRPA in elder patients and the pairs of CTLA4-CD86 and TIGIT-NECTIN2 in younger patients. This study reveals the distinct immune profiles between younger and elder NSCLC patients, and the elder patients were likely to exhibit a more immunosuppressive TME and attenuated tumor-killing capability compared with younger patients.

The contents and clinical significance of CD28 and CTLA-4 mRNA in peripheral blood of elderly patients with primary non-small cell lung cancer

Expression and its clinical significance of the membrane CD28 and the serum level of soluble CD28 in elderly patients with primary non-small cell lung cancer

Influence of age and comorbidity on treatment strategies and survival time of elderly patients with advanced non-small cell lung cancer

The expression and clinical significance of Fas/FasL on T cells in peripheral blood of elderly patients with primary non-small cell lung cancer

Changes in CD4+CD25+Foxp3+ Regulatory T Cells in Relation to Aging and Lung Tumor Incidence

Changes of Regulatory T Cells and FoxP3 Gene Expression in the Aging Process and Its Relationship with Lung Tumors in Humans and Mice.

[Quantitative Studies on Expression of Peripheral Blood CD44 and CD54 in Non-Small Cell Lung Carcinoma].

The frequency and clinical significance of CD4+CD25+ regulatory T cells in peripheral blood from elderly tumor patients

Single-cell analysis reveals the disparities in immune profiles between younger and elder patients

The Predictive Value of Tumor Mutation Burden for Immune Checkpoint Inhibitors Therapy in Non-Small Cell Lung Cancer is Affected by Patients’ Age

Analysis of the Characteristics and Prognosis of Advanced Non-Small-Cell Lung Cancer in Older Patients

P2-325: Chemotherapy in elderly (Over 75 years old)lung cancer patients: a retrospective analysis

Expression and Its Significance of the Membrane CD28 in T Cells and the Serum Level of Soluble CD28 in Elders

[A Retrospective Analysis: Comparison of the Clinical Characteristics and Prognosis in Elderly and Young Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer.].

CD4~+ CD25~+-regulatory T cells in peripheral blood from patients with non small cell lung carcinoma

Analysis of Survival Data in Patients with Advanced Non-Small-Cell Lung Cancer Aged 60 Years and Over

Clinical retrospective observation of lung cancer between young and elderly patients

Expression of regulatory T cells in the peripheral blood and its clinical significance in patients with non-small cell lung cancer

Elderly Lung Cancer Patients show Tumor-Infiltrating CD8+ T Cell Responses Enriched with PDCD1 and CXCL13 after Neoadjuvant Therapy with Anti-PD-1

The expression features and clinical significance of CD4+ CD25+ regulatory T cells in elderly patients with acute myelocytic leukemia

Prognostic Factors and Clinical Features of 150 Elderly Patients with Non-Small Cell Lung Cancer